XML 56 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Equity Compensation (Tables)
 12 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity in Total Shares Available for Grant
The following table summarizes the activity in total shares available for grant (in thousands):
 
 Shares
 Available for
 Grant
Balance, March 29, 20252,540 
Granted(1,163)
Forfeited203 
Balance, March 28, 20261,580 
Schedule of Effect of Stock-Based Compensation
The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted under the Plan (in thousands, except per share amounts):
 
 Fiscal Year
 202620252024
Cost of sales$976 $1,332 $1,403 
Research and development51,698 59,184 63,678 
Sales, general and administrative29,137 23,630 24,190 
Effect on pre-tax income81,811 84,146 89,271 
Income Tax Benefit(17,687)(19,152)(20,646)
Total stock-based compensation expense (net of taxes)64,124 64,994 68,625 
Stock-based compensation effects on basic earnings per share$1.25 $1.22 $1.26 
Stock-based compensation effects on diluted earnings per share1.21 1.18 1.22 
Schedule of Fair Value Assumptions for Stock Option Grants In fiscal years 2025 and 2024, we estimated the fair value of each stock option on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions:
 
March 29, 2025March 30, 2024
Expected stock price volatility
35.70%
34.53% - 39.92%
Risk-free interest rate
4.33%
3.99% - 4.11%
Expected term (in years)
3.73
3.85 - 4.07
Schedule of Stock Option Activity
Additional information with respect to stock option activity is as follows (in thousands, except per share amounts):
 
 Outstanding Options
NumberWeighted
Average
Exercise Price
Balance, March 29, 2025504 $81.53 
Options exercised(67)57.44 
Options forfeited(8)96.22 
Balance, March 28, 2026429 $85.06 
Schedule of Additional Information Regarding Outstanding Options that are Vesting, Expected to Vest or Exercisable
Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 28, 2026 is as follows (in thousands, except years and per share amounts):
 
Number of
Options		Weighted
Average
Exercise price		Weighted Average
Remaining Contractual
Term (years)		Aggregate
Intrinsic Value
Vested and expected to vest426 $84.98 6.00$24,872 
Exercisable348 $82.41 5.65$21,237 
Schedule of Outstanding and Exercisable Options
The following table summarizes information regarding outstanding and exercisable options as of March 28, 2026 (in thousands, except per share amounts):
 
 Options OutstandingOptions Exercisable
Weighted Average
Remaining
Contractual Life		Weighted
Average Exercise		NumberWeighted
Average
Range of Exercise PricesNumber(years)PriceExercisableExercise Price
$38.15 - $88.00
228 4.77$73.61 226 $73.53 
$93.24 - $129.24
201 7.4398.07 122 98.77 
429 6.02$85.06 348 $82.41 
Schedule of RSU Activity A summary of the activity for RSUs in fiscal year 2026 is presented below (in thousands, except per share amounts):
 
SharesWeighted
Average
Fair Value
March 29, 20252,532 $81.04 
Granted710 120.61 
Vested(948)75.81 
Forfeited(126)87.16 
March 28, 20262,168 $95.94 
Schedule of Additional Information Regarding Outstanding RSUs Expected to Vest Additional information with regards to outstanding RSUs that are expected to vest as of March 28, 2026, is as follows (in thousands, except year and per share amounts):
 
SharesWeighted
Average
Fair Value		Weighted Average
Remaining Contractual
Term (years)
Expected to vest2,061 $95.32 1.42
Schedule of Monte Carlo Simulation Assumptions for MSUs
The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero and the following additional assumptions:
 
 Fiscal Years Ended
March 28,
2026		March 29,
2025		March 30,
2024
Expected stock price volatility
40.40%
39.34% - 41.61%
34.53%
Risk-free interest rate
3.52%
3.97% - 4.15%
4.12%
Expected term (in years)3.003.003.00
Schedule of MSU and PSU Activity
A summary of the activity for MSUs in fiscal year 2026 is presented below (in thousands, except per share amounts):

 
SharesWeighted
Average
Fair Value
March 29, 2025104 $152.23 
Granted64 203.35 
Vested(38)128.94 
Forfeited(1)141.48 
March 28, 2026129 $182.90 
A summary of the activity for PSUs in fiscal year 2026 is presented below (in thousands, except per share amounts):

SharesWeighted Average Fair Value
March 29, 2025109 $104.41 
Granted1 109.42 
Vested— — 
Forfeited(3)104.41 
March 28, 2026107 $104.48 
Schedule of Outstanding MSUs and PSUs Expected to Vest Additional information with regard to outstanding MSUs that are expected to vest as of March 28, 2026 is as follows (in thousands, except year and per share amounts):
 
SharesWeighted
Average
Fair Value		Weighted Average
Remaining Contractual
Term (years)
Expected to vest119 $182.09 2.06
Additional information with regard to outstanding PSUs that are expected to vest as of March 28, 2026 is as follows (in thousands, except year and per share amounts):
 
SharesWeighted Average Fair ValueWeighted Average Remaining Contractual Term (years)
Expected to vest142 $104.46 1.50